Skip to main content

Table 3 Result overview of the complete cohort values given in mean and standard deviation

From: Safety of various parameter sets with navigated microsecond pulsing laser in central serous chorioretinopathy

 

All patients

Total Number of included eyes

101

Resolution of subretinal fluid

 Worsened

2 (2%)

 Persistent

31 (31%)

 Recurrent

2 (2%)

 Partially resolved

12 (12%)

 Completely resolved

54 (54%)

BCVA development

 Baseline

0.35 ± 0.3

 Last follow up

0.27 ± 0.31

 P

0.02*

 Gain

− 0.07 ± 0.2

 Patients with > 5 letters loss

13 (13%)

 Patients with stability

53 (53%)

 Patients with > 5 letter gain

35 (35%)

CRT reduction

 

 Baseline

325 ± 130

 Last follow up

255 ± 115

 P

 < 0.001*

 Loss

− 70 ± 143

 Number of MSP treatment

1.34 (1–3)

 Additional treatment with other treatment modality

9/101 (9%)

 adverse events from laser

0/101 (0%)

  1. Values given in mean and Standard deviation
  2. CRT Central retinal thickness, MSP microsecond pulsing laser, BCVA Best Corrected visual acuity